54m
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data
The clinical trial data that caused one pharmaceutical company to walk away from acquiring Terns Pharmaceuticals also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results